Why the study?
What are the mechanisms by which antiplatelet drugs exert anti-inflammatory effects in patients with ACS and CAD?
Population
Patients with acute coronary syndrome (ACS) and coronary artery disease (CAD)
Design
Review
Authors
Loading...
May inform antiplatelet choice in ACS/CAD; leaves open whether anti-inflammatory effects alter outcomes.
What are the mechanisms by which antiplatelet drugs exert anti-inflammatory effects in patients with ACS and CAD?
This review highlights the dual role of antiplatelet therapy in inhibiting aggregation and modulating chronic inflammation in cardiovascular disease.
Müller et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: